Quadria Capital To Use $300 Million Fund To Close Deals In Asia
Quadria Capital, a private equity fund focused on healthcare, is in the process of closing four deals by the end of March. The firm, with its plan to invest on four companies in Southeast Asia, will deploy its $300 million fund.
According to Amit Varma, co-founder and managing partner of Quadria Capital, they are in talks with companies in Thailand, Vietnam and Singapore. They might also do another deal in the Philippines. The firm is also working on closing out a deal in India.
Quadria Capital, which was founded in 2010, has already invested in 15 companies across six countries in the South and Southeast Asian regions. Its founders, Varma and Abrar Mir, were holding senior positions in Religare Group businesses before starting Quadria.
The fund has a committed capital pool of $300 million. It also has an additional $200 million of co-investment commitments from its limited partners.
"We are a 10-member investment team out of which four are based out of Mumbai office and four are based out of Singapore office, which is also reflection of how the fund is being spent. Sixty percent of the fund will go into Southeast Asia and remaining 40% will go into South Asia," said Varma.
The firm has made four investments from its latest funds. Three of these investments, which are located in India, include Concord Biotech Ltd, Asian Institute of Gastroenterology, and Medica Hospitals. Its lone investment in Southeast Asia is Soho Global Health, located in Indonesia.
The firm currently does not have any immediate plans of raising another fund.
"We plan to completely deploy in 2017, then take a year to ensure that we are monitoring the portfolio companies and a year after that we would look at the second fund. It will be prudent to spend time growing these companies," he said.